Product NDC: | 66336-338 |
Proprietary Name: | METHOTREXATE |
Non Proprietary Name: | METHOTREXATE |
Active Ingredient(s): | 2.5 mg/1 & nbsp; METHOTREXATE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66336-338 |
Labeler Name: | Dispensing Solutions, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA008085 |
Marketing Category: | NDA |
Start Marketing Date: | 19531207 |
Package NDC: | 66336-338-21 |
Package Description: | 21 TABLET in 1 BOTTLE (66336-338-21) |
NDC Code | 66336-338-21 |
Proprietary Name | METHOTREXATE |
Package Description | 21 TABLET in 1 BOTTLE (66336-338-21) |
Product NDC | 66336-338 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | METHOTREXATE |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19531207 |
Marketing Category Name | NDA |
Labeler Name | Dispensing Solutions, Inc. |
Substance Name | METHOTREXATE SODIUM |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |